Sanofi and Regeneron Begin Initial Covid-19 Treatment Trials

March 18, 2020

Sanofi and Regeneron Pharmaceuticals Inc. will soon begin evaluating an experimental treatment in patients hospitalized with severe Covid-19, the drugmakers said Monday.

Related Stories